Utility of hydroxychloroquine laboratory monitoring in dermatologic and rheumatologic patients
Crossref DOI link: https://doi.org/10.1007/s00403-024-02876-7
Published Online: 2024-05-22
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Green, Maxwell
Williams, Laura
Boh, Erin
Kuraitis, Drew
Text and Data Mining valid from 2024-05-22
Version of Record valid from 2024-05-22
Article History
Received: 2 January 2024
Revised: 19 February 2024
Accepted: 7 April 2024
First Online: 22 May 2024
Declarations
:
: The authors declare no competing interests.
: None.